San Francisco, CANCT06631365Now EnrollingIRB Ready

HIV-1-infection Clinical Trial in San Francisco, CA

Access cutting-edge hiv-1-infection treatment through this phase 2 clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Public Health Foundation Enterprises, Inc.

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access hiv-1-infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv-1-infection treatment provided free

Apply for This San Francisco Location

Check if you qualify for this hiv-1-infection clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This HIV-1-infection Study in San Francisco

This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly innovative tool to support men who have sex with men (MSM) using on-demand PrEP ready for testing in a larger efficacy trial

Sponsor: Public Health Foundation Enterprises, Inc.

Who Can Participate

Inclusion Criteria

Age 18 years or older
Cisgender-male who reports sex with persons assigned male at birth
Willing and able to provide written informed consent
HIV-uninfected by negative 4th generation HIV test during screening (prescribed group)
Documentation of negative HIV test within the last 3 months by outside laboratory OR evidence of PrEP prescription within the last 6 months based on medical records or pharmacy/provider communication
Owns an iOS or Android mobile phone with a camera and has private access to the internet
Able to understand, read, and speak English
Able to attend study visits at a local research site in San Francisco (Bridge HIV) (prescribed and non-prescribed groups) or virtual visits via a HIPAA-compliant teleconferencing platform (non-prescribed group)
Interested in starting or currently taking on-demand PrEP with TDF/FTC
Report having anal sex at least once a month and expecting to maintain at least this frequency of anal sex during study participation by self-report
Creatinine clearance ≥60 mL/min based on testing done during screening (prescribed group)
Have PrEP clinical and laboratory monitoring by another provider or clinic by self-report (non-prescribed group)
No contraindications to TDF/FTC use
No evidence of chronic HBV infection based on testing done during screening (prescribed group)
Willing to self-collect urine samples weekly

Exclusion Criteria

Repeatedly reactive HIV test at screening or enrollment or self-reported reactive HIV test (prescribed group)
Signs or symptoms of acute HIV infection at screening or enrollment
Currently enrolled in another PrEP intervention study.
Unable to commit to study participation for the duration of the study
Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06631365) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV-1-infection Treatment Options in San Francisco, CA

If you're searching for hiv-1-infection treatment options in San Francisco, CA, this clinical trial (NCT06631365) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced hiv-1-infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv-1-infection clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in San Francisco, CA

See all hiv aids clinical trials recruiting in San Francisco — not just this study.

Browse HIV AIDS Trials in San Francisco →

Browse More Trials by Condition

HIV AIDS TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA